Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2015 (2015), Article ID 142408, 4 pages
http://dx.doi.org/10.1155/2015/142408
Case Report

Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy

1Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University, Damas Street, P.O. Box 17-5208, Beirut, Lebanon
2Department of Ophthalmology, Faculty of Medicine, Saint Joseph University, Damas Street, P.O. Box 17-5208, Beirut, Lebanon
3Department of Radiotherapy, Faculty of Medicine, Saint Joseph University, Damas Street, P.O. Box 17-5208, Beirut, Lebanon
4Department of Ophthalmology, Eye & Ear Hospital, Naccash Road, Mar Mansour Street, P.O. Box 70-933 Dbayeh, Beirut, Lebanon

Received 1 December 2014; Revised 28 February 2015; Accepted 10 March 2015

Academic Editor: Claudio Campa

Copyright © 2015 Hampig Raphael Kourie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Choroidal metastasis from lung cancer is uncommon. We report a case of choroidal metastasis as an inaugural manifestation of lung adenocarcinoma, successfully treated by docetaxel, cisplatinum, and intravenous bevacizumab as an antiangiogenesis therapy. A complete remission was obtained after 4 cycles and maintained after six cycles. This case report demonstrates the importance of the systemic bevacizumab and chemotherapy in the treatment of choroidal metastasis from adenocarcinoma of the lung.